Patent · US Active

Biosynthetic heparin

US11591628B2 · kind B2 · utility

0Cited by
0References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 7, 2017
Grant dateFeb 28, 2023
Priority date—
Expiry dateFeb 18, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y208/02001
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present disclosure relates to synthesis of heparin, which may be bioequivalent to porcine USP Heparin Sodium. The synthesis may involve three intermediates starting from heparosan.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.